GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » Deferred Policy Acquisition Costs

Yuhan (XKRX:000100) Deferred Policy Acquisition Costs


View and export this data going back to 1962. Start your Free Trial

What is Yuhan Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Yuhan (XKRX:000100) Business Description

Industry
Traded in Other Exchanges
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.